Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Arigene to terminate Trimeris tender offer
Marketwatch
Tuesday, December 29, 2009 - 9:48am
tags:
Trimeris, Arigene, M&A
FDA: J&J recalling contaminated Tylenol bottles
Marketwatch
Tuesday, December 29, 2009 - 9:36am
tags:
recalls, Tylenol, JNJ
Eli Lilly Deal to Sell Livalo Not Without Risks
BNET Pharma
Tuesday, December 29, 2009 - 9:17am
tags:
Livalo, Eli Lilly, Kowa, anti-clotting
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
Kowa Pharmaceuticals
Tuesday, December 29, 2009 - 9:16am
tags:
Eli Lilly, Kowa, copromotion, Livalo
Vivus files application with FDA for obesity drug
Marketwatch
Tuesday, December 29, 2009 - 9:14am
tags:
FDA, Vivus, obesity, Qnexa
Pharmaxis Shares Fall After FDA Turns Down Aridol
Bloomberg
Tuesday, December 29, 2009 - 9:08am
tags:
FDA, Pharmaxis, Aridol
IPOs to test financial, biotech appetite
Yahoo/Reuters
Tuesday, December 29, 2009 - 9:07am
tags:
IPOs, Merck, Pfizer, Codexis
Johnson & Johnson: A Compelling Investment Opportunity
Seeking Alpha
Tuesday, December 29, 2009 - 9:06am
tags:
JNJ
Sinovac Biotech files for approval of vaccine for virus behind hand, foot, and mouth disease
Yahoo/AP
Monday, December 28, 2009 - 4:28pm
tags:
vaccines, Sinovac, hand foot and mouth disease
Tengion blueprints $40M IPO
Fierce Biotech
Monday, December 28, 2009 - 4:27pm
tags:
Tengion, IPOs
FDA Delays Nuvigil Decision
Yahoo/Zacks.com
Monday, December 28, 2009 - 4:25pm
tags:
NUVIGIL, FDA, Cephalon, Teva Pharmaceuticals, Mylan
Setback for Gilead's Pipeline
Yahoo/Zacks.com
Monday, December 28, 2009 - 10:20am
tags:
Gilead Sciences, darusentan
Shire Seeks FDA Approval
Yahoo/Zacks.com
Monday, December 28, 2009 - 10:18am
tags:
Shire, FDA, Fabry's disease, Replagal, Genzyme
Trimeris sale in jeopardy again
Bizjournals.com
Monday, December 28, 2009 - 10:17am
tags:
Trimeris, South Korea, Arigene, M&A
La Jolla Pharmaceutical Finally Slain by the Wolf as Luck Runs Out
BNET Pharma
Monday, December 28, 2009 - 10:15am
tags:
La Jolla Pharmaceutical, Riquent, lupus
Vical melanoma drug gets positive safety review
Yahoo/AP
Monday, December 28, 2009 - 10:14am
tags:
Vical, melanoma, Allovectin-7
Cell Therapeutics adopts 'poison pill' plan
Yahoo/AP
Monday, December 28, 2009 - 10:13am
tags:
poison pill, Cell Therapeutics, FDA, cancer, pixantrone
Merck Ends deal with Arena
Yahoo/Zacks.com
Monday, December 28, 2009 - 10:07am
tags:
Arena Pharmaceuticals, obesity, Merck, atherosclerosis, Orexigen
Generics chafe under big pharma's US reform shadow
Guardian/Reuters
Monday, December 28, 2009 - 6:04am
tags:
generics, healthcare reform, biogenerics
The genetic revolution takes aim at the pipeline
Fierce Biotech
Monday, December 28, 2009 - 5:03am
tags:
sequencing, personalized medicine, R&D, Knome, Pacific Biosciences, Complete Genomics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.